Neion Bio
Neion Bio is a biotechnology company that develops life-saving products derived from nature molecular factories, utilizing advanced genetic engineering to harness the power of biology for creating innovative therapeutic solutions. The company technology leverages principles of evolutionary biology and genetic engineering to develop transformative products, focusing on natural molecular factories as a source of novel…
Funding snapshot
About
Neion Bio is a biotechnology company that develops life-saving products derived from nature molecular factories, utilizing advanced genetic engineering to harness the power of biology for creating innovative therapeutic solutions. The company technology leverages principles of evolutionary biology and genetic engineering to develop transformative products, focusing on natural molecular factories as a source of novel compounds with therapeutic potential. Neion Bio approach enables the discovery and development of new treatments by engineering biological systems to produce molecules that may be difficult or impossible to synthesize through traditional chemical methods. The company platform is designed to create innovative solutions for unmet medical needs by tapping into the diversity of natural biosynthetic pathways. Founded in 2024 and headquartered in New York City, Neion Bio has raised $23 million in Series A funding from investors including Caffeinated, Basis Set Ventures, Haystack, Digitalis Ventures, Ensemble, and Trust Ventures.
Business model
Genomics > Enabling Technologies > Technology Platforms > Genetic Engineering
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.